Africa: Africa CDC and Geneva Learning Foundation Partner to Strengthen Immunisation

Africa: Ebola Response Shows Progress, but Outbreak Remains a Continental Emergency, African Scientists Say

[Africa CDC] Addis Ababa, Ethiopia -- Four months after the Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo was designated a Public Health Emergency of Continental…

3h ago ·allafrica.com

Africa: G20+ Mobilises U.S.$2.9 Billion for Ebola Response As Africa CDC Calls for Full Transparency and Traceability of Every Dollar

[Africa CDC] New York/Addis Ababa, 24 September 2026

3h ago ·allafrica.com

Africa: Paho and Africa CDC Call for Sustained Investment and Stronger Africa-Americas Cooperation On Pandemic Preparedness

[Africa CDC] At UNGA, Burundi and Guyana joined PAHO and Africa CDC to advance country-led cooperation and financing for pandemic prevention, preparedness and response

3h ago ·allafrica.com

Africa: Africa CDC Welcomes Increased UK Support to Ebola Response

[Africa CDC] Africa CDC welcomes the United Kingdom Government's decision to increase its support to the Ebola response in the Democratic Republic of the Congo, bringing its total commitment to £78.7…

3h ago ·allafrica.com

Africa: Africa CDC Welcomes Increased UK Support to Ebola Response

[Africa CDC] Africa CDC welcomes the United Kingdom Government's decision to increase its support to the Ebola response in the Democratic Republic of the Congo, bringing its total commitment to £78.7…

3h ago ·allafrica.com

Innovent Biologics expands Phase 3 lung cancer trial globally

Biopharmaceutical manufacturer Innovent Biologics expanded its global Phase 3 MarsLight 11 clinical trial of candidate IBI363 TAK 928 to evaluate patients with immunotherapy resistant non squamous non…

• Innovent Biologics expands MarsLight-11 Phase 3 lung cancer trial globally.
• Trial now includes non-squamous non-small cell lung cancer patients.
• IBI363/TAK-928 bispecific fusion protein assessed against docetaxel.

3h ago ·vir.com.vn